Does ALECTINIB Cause Metastases to central nervous system? 161 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Metastases to central nervous system have been filed in association with ALECTINIB (ALECENSA). This represents 1.8% of all adverse event reports for ALECTINIB.
161
Reports of Metastases to central nervous system with ALECTINIB
1.8%
of all ALECTINIB reports
12
Deaths
28
Hospitalizations
How Dangerous Is Metastases to central nervous system From ALECTINIB?
Of the 161 reports, 12 (7.5%) resulted in death, 28 (17.4%) required hospitalization, and 12 (7.5%) were considered life-threatening.
Is Metastases to central nervous system Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 161 reports have been filed with the FAERS database.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Disease progression (366)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
What Other Drugs Cause Metastases to central nervous system?
TRASTUZUMAB (1,180)
CAPECITABINE (663)
OSIMERTINIB (560)
PERTUZUMAB (540)
PACLITAXEL (498)
NIVOLUMAB (495)
DABRAFENIB (451)
CARBOPLATIN (413)
DOCETAXEL (410)
ADO-TRASTUZUMAB EMTANSINE (386)
Which ALECTINIB Alternatives Have Lower Metastases to central nervous system Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE